Riskpilot← Back to searchSign inGet full accessGlobal Orthopaedic Laboratory AB
ABActiveOrg 5562059435Magnus Paulins Gata 1Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19800 employees
Revenue 2024
SEK 0
EBITDA margin
—
+224% vs 2023
Equity ratio
98.0%
Financial strength
Net profit 2024
SEK 1,9M
+68% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK 68K | +224% |
| Net profit | SEK 1,9M | +68% |
| Total assets | SEK 21,2M | -10% |
| Equity | SEK 20,8M | -8% |
| Employees | 0 | — |
Legal name
Global Orthopaedic Laboratory AB
Org number
5562059435
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
25 augusti 1980
Share capital
SEK 250 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall ägna sig åt ortoped och ortopedteknisk verksamhet, bolaget ska även handla och förmedla specialprodukter och service med \know how\ till sjukvården och därmed förenlig verksamhet.
Address
Magnus Paulins Gata 1
Phone
+4642126613
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 23 | 57 | −190 | 21 | 68 |
| Depreciation & amort. | −46 | −46 | −46 | −41 | −41 |
| EBIT | −23 | 11 | −236 | −20 | 27 |
| Net financials | 1 440 | 349 | 4 622 | 1 222 | 1 967 |
| Profit before tax | 1 204 | 360 | 4 386 | 1 202 | 1 993 |
| Tax | −137 | −19 | −604 | −58 | −75 |
| Net profit | 1 067 | 341 | 3 782 | 1 144 | 1 918 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 233 | 18 066 | 22 306 | 23 482 | 21 174 |
| Equity | 18 815 | 17 656 | 21 438 | 22 582 | 20 750 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 191 | 184 | 641 | 673 | 197 |
| Total debt | 191 | 184 | 641 | 673 | 197 |
EBITDA margin
6800000.0%
This company
15.8%
Market median
+43037875% vs market
20202024
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20202024
Net profit margin
191800000.0%
This company
8.1%
Market median
+2367901135% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PO | Audit | 2024 |
BA Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
SP Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Global Orthopaedic Laboratory AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Peter Roubert | Audit | 0 companies |
| Peter Ola Villy Björn | Audit | 0 companies |
| Bengt Anders Söderberg | Chief Executive Officer | 0 companies |
| Helle Möller Söderberg | Deputy Board Member | 0 companies |